SCHEMBL9102564

SCHEMBL9102564

CCC(=O)N[C@H]1CC[C@H](NC(=O)c2c(C)[nH]c3c(-c4ccc(OC)cc4OCC4CC4)ccnc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.40
GRIN2B Q13224 2/20 0.40
RAB9A P51151 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
AURKA O14965 1/20 0.36
MET P08581 1/20 0.36
KDR P35968 1/20 0.36
TEK Q02763 1/20 0.36
CDK9 P50750 2/20 0.36
RIPK2 O43353 2/20 0.36
CASP3 P42574 1/20 0.36
CASP7 P55210 1/20 0.36
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
SMYD3 Q9H7B4 1/20 0.35
BTK Q06187 1/20 0.35
PRKACA P17612 1/20 0.35
PRKACG P22612 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9102760 1.00 GRIN1 (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL9102575 1.00 GRIN1 (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL1437839 0.94 GRIN1 (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL9103949 0.94 GABRG2 (0.38) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL1437845 0.94 GRIN1 (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL9107615 0.94 GABRG2 (0.38) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL9103941 0.94 GABRG2 (0.38) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL1437841 0.94 GRIN1 (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL1437379 0.93 KDM4E (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1
SCHEMBL9106281 0.93 KDM4E (0.40) GRIN1GRIN2BRAB9AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US claimed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US claimed
US-8816085-B2 Methylpyrrolopyridinecarboxamides TAKEDA GMBH (DE) 2014-08-26 US disclosed
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142633-A1 METHYLPYRROLOPYRIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A GRIN1 2326/4885GRIN2B 2349/4885RAB9A 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.